IP Library Granted Patent US 8,469,935
Granted Patent B2
US 8,469,935 · App. 13/043,987 · Granted Jun 25, 2013

Abdominal treatment systems, delivery devices, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,469,935
App. No.
13/043,987
Granted
Jun 25, 2013
Kind
B2
Abstract

A reduced-pressure abdominal treatment device is presented that has a plurality of liquid-impermeable layers with a foam spacer between two of the liquid-impermeable layers. The plurality of liquid-impermeable layers have a coextensive area A 1 . The foam spacer has a plan-view area A 2 . A 2 is less than 80% of A 1 (i.e., A 2 <0.8A 1 ). The foam spacer is configured such that, under reduced pressure, a target fluid removal zone experiences reduced-pressure vectors over an angle theta (θ) that is typically 360 degrees for a majority of locations in the target fluid removal zone. Applying 360 degrees of reduced pressure helps avoid blockage. The plurality of liquid-impermeable layers may be bonded for various effects. Other devices, systems, and methods are disclosed.

Claims (49)

1. An abdominal treatment device for distributing reduced pressure to a tissue site, the abdominal treatment device comprising:

a plurality of liquid-impermeable layers wherein the liquid-impermeable layers are at least partially fenestrated;

a micro-channel space between the liquid-impermeable layers;

a foam spacer disposed between the liquid-impermeable layers, wherein the foam spacer comprises arc members interconnected to form at least one window; and

spacer bonds coupling at least two of the liquid-impermeable layers and disposed along a peripheral edge of the window;

wherein the liquid-impermeable layers have a coextensive area A 1 ;

wherein the foam spacer has a plan-view area A 2 ;

wherein A 2 is less than 80% of A 1 ; and

wherein the foam spacer is configured such that, under reduced pressure, a location in the micro-channel space experiences reduced-pressure vectors over an angle theta (θ) that is at least 300 degrees.

2. The abdominal treatment device of claim 1 , wherein the angle theta (θ) is 360 degrees for more than 70 percent (70%) of locations in the micro-channel space.

3. The abdominal treatment device of claim 1 , wherein the spacer bonds comprise a stitch bond.

4. The abdominal treatment device of claim 1 , wherein the arc members are elliptical members.

5. A system for treating an abdominal cavity with reduced pressure, the system comprising:

an abdominal treatment device comprising:

a plurality of liquid-impermeable layers, wherein the plurality of liquid-impermeable layers has have a coextensive area A 1 and are fenestrated,

a micro-channel space between the liquid-impermeable layers;

a foam spacer disposed between at least two layers of the plurality of liquid-impermeable layers, the foam spacer having a plan-view area A 2 and comprising arc members interconnected to form at least one window, and

spacer bonds coupling the two layers of the plurality of liquid impermeable layers and disposed along a peripheral edge of the window,

wherein A 2 is less than 80% of A 1 , and

wherein the foam spacer is configured such that, under reduced pressure, a location in the micro-channel space experiences reduced-pressure vectors over an angle theta (θ) that is at least 300 degrees;

a reduced-pressure source fluidly coupled to the abdominal treatment device.

6. The system of claim 5 , wherein the angle theta (θ) is 360 degrees for more than 70 percent of locations in the micro-channel space.

7. The system of claim 5 , further comprising a reduced-pressure conduit and a reduced-pressure connector subsystem for fluidly coupling the reduced-pressure source to the abdominal treatment device.

8. The system of claim 5 , wherein the spacer bonds comprise a solid bond.

9. The system of claim 5 , wherein the arc members are elliptical members.

10. The system of claim 5 , wherein the arc members are concentric circular members.

11. A method of manufacturing an abdominal treatment device, the method comprising the steps of:

providing a plurality of liquid-impermeable layers that are fenestrated;

placing the plurality of liquid-impermeable layers adjacent one another, wherein the plurality of liquid-impermeable layers has have a coextensive area A 1 ;

disposing a foam spacer between at least two layers of the plurality of liquid-impermeable layers, the foam spacer comprising arc members interconnected to form at least one window;

bonding at least two of the liquid-impermeable layers along a peripheral edge of the window to form a micro-channel space between the liquid-impermeable layers;

wherein the foam spacer has a plan-view area A 2 and A 2 is less than 80% of A 1 ;

wherein the foam spacer is configured such that, under reduced pressure, a location in the micro-channel space experiences reduced-pressure vectors over an angle theta (θ) that is 3-60 at least 300 degrees.

12. The method of manufacturing an abdominal treatment device of claim 11 , wherein the angle theta (θ) is 360 degrees for more than 70 percent of locations in the micro-channel space.

13. The method of manufacturing an abdominal treatment device of claim 11 , wherein the arc members are elliptical members.

14. A method of treating a tissue site in an abdominal cavity, the method comprising the steps of:

opening the abdominal cavity;

deploying within the abdominal cavity an abdominal treatment delivery device;

deploying a reduced-pressure connector subsystem;

deploying a sealing member to form a fluid seal over the abdominal cavity;

fluidly coupling the reduced-pressure connector subsystem to a reduced-pressure source;

activating the reduced-pressure source; and

wherein the abdominal treatment delivery device comprises:

a plurality of liquid-impermeable layers, wherein the plurality of liquid-impermeable layers has have a coextensive area A 1 and are fenestrated;

a micro-channel space between the liquid-impermeable layers;

a foam spacer disposed between at least two layers of the plurality of liquid-impermeable layers, the foam spacer having a plan-view area A 2 and comprising arc members interconnected to form at least one window; and

spacer bonds disposed between the two layers of the plurality of liquid impermeable layers along a peripheral edge of the window;

wherein A 2 is less than 80% of A 1 ;

wherein the foam spacer is configured such that, under reduced pressure, a location in the micro-channel space experiences reduced-pressure vectors over an angle theta (θ) that is at least 300 degrees.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2011
From: SIMMONS, TYLER; SAMMONS, ALEXANDER G.
To: KCI LICENSING, INC.
Reel/Frame 026162/0627 →